Regulatory bodies across different countries are gradually shifting towards a more favorable stance for eConsent adoption. It allows trial participants to be provided with the information they need to make a decision at their own convenience – anywhere and anytime. However, regulations about the use of it can vary widely across borders. Get ready for potential regulatory changes that may affect the way you conduct research in 24 countries. This white paper covers the eConsent adoption landscape, country- specific legislation, and the practicalities of using eConsent in your clinical trial.


Countries covered:

  1. Australia
  2. Austria
  3. Belgium
  4. Brazil
  5. Canada
  6. China
  7. Denmark
  8. Finland
  9. France
  10. Germany
  11. India
  12. Ireland
  13. Israel
  14. Italy
  15. Japan
  16. Netherlands
  17. Poland
  18. Singapore
  19. South Korea
  20. Spain
  21. Sweden
  22. Switzerland
  23. United Kingdom
  24. United States
Download nowDownload now
Related tags

Share article